创伤性脑损伤中的组学研究:复杂疾病的新方法
本文为叙述性综述,阐述基因组学、蛋白质组学和代谢组学等组学技术如何应用于创伤性脑损伤(TBI)的诊断、预后判断及损伤机制研究。组学平台可分析小样本中的大量分子信息,结合生物信息学与临床数据,有望推动TBI精准医学、药物研发及个体化治疗。
要点
- 组学技术可助力TBI诊断与预后判断。
- 组学有助于揭示TBI继发性损伤的分子机制。
- 组学数据与临床数据结合可构建预后预测模型。
核心结论
- TBI组学研究领域正快速发展,近期数据与新方法可能为精准医学方法、药物研发及个体化治疗奠定基础。
研究设计与样本
- 叙述性综述,概述组学技术(基因组学、蛋白质组学、代谢组学)在TBI研究中的应用。
主要发现
- 组学平台可研究正常与TBI疾病状态下分子通路的功能、动态变化及改变。
- 通过先进生物信息学,可对少量生物样本产生的大数据集进行详细分析,提供病理生理机制知识。
- 组学使从与继发性损伤易感性或不良预后相关的基因组成,到TBI后代谢物潜在改变等广泛研究成为可能。
临床怎么用
- 组学可与临床相关数据连接,用于预后建模。
- 组学有助于推动TBI精准医学方法、药物研发及治疗个体化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To date, there is neither any pharmacological treatment with efficacy in traumatic brain injury (TBI) nor any method to halt the disease progress. This is due to an incomplete understanding of the vast complexity of the biological cascades and failure to appreciate the diversity of secondary injury mechanisms in TBI. In recent years, techniques for high-throughput characterization and quantification of biological molecules that include genomics, proteomics, and metabolomics have evolved and referred to as omics. METHODS: In this narrative review, we highlight how omics technology can be applied to potentiate diagnostics and prognostication as well as to advance our understanding of injury mechanisms in TBI. RESULTS: The omics platforms provide possibilities to study function, dynamics, and alterations of molecular pathways of normal and TBI disease states. Through advanced bioinformatics, large datasets of molecular information from small biological samples can be analyzed in detail and provide valuable knowledge of pathophysiological mechanisms, to include in prognostic modeling when connected to clinically relevant data. In such a complex disease as TBI, omics enables broad categories of studies from gene compositions associated with susceptibility to secondary injury or poor outcome, to potential alterations in metabolites following TBI. CONCLUSION: The field of omics in TBI research is rapidly evolving. The recent data and novel methods reviewed herein may form the basis for improved precision medicine approaches, development of pharmacological approaches, and individualization of therapeutic efforts by implementing mathematical "big data" predictive modeling in the near future.
引用
- Abu Hamdeh S, Tenovuo O, Peul W, et al. "Omics" in traumatic brain injury: novel approaches to a complex disease. Acta Neurochir (Wien). 2021. PMID: 34273044. doi:10.1007/s00701-021-04928-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。